PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
61.53%
Cash & equivalents yoy growth at least 1.5x AVXL's 1.45%. Mohnish Pabrai might see this as a favorable liquidity edge, provided funds are well deployed.
No Data
No Data available this quarter, please select a different quarter.
61.53%
Cash + STI yoy ≥ 1.5x AVXL's 1.45%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.75%
≥ 1.5x AVXL's 2.15%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
529.47%
Higher PP&E (Net) Growth compared to AVXL's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
588.21%
Higher Total Non-Current Assets Growth compared to AVXL's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
63.35%
≥ 1.5x AVXL's 2.15%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
9.62%
Less than half of AVXL's -43.21%. David Dodd sees a more disciplined AP approach or lower volume.
59.49%
Higher Short-Term Debt Growth compared to AVXL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
103.88%
Higher Deferred Revenue (Current) Growth compared to AVXL's zero value, indicating better performance.
-531.94%
Higher Other Current Liabilities Growth compared to AVXL's zero value, indicating worse performance.
9.77%
Less than half of AVXL's -23.34%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1866750.00%
Less than half of AVXL's -39.44%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
661.90%
Less than half of AVXL's -23.34%. David Dodd sees far fewer liability expansions relative to competitor.
13.64%
Above 1.5x AVXL's 1.32%. Michael Burry suspects heavy new equity expansion or dilution.
-2.98%
0.5-0.75x AVXL's -5.01%. Martin Whitman is wary of weaker retention or lower profitability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.57%
≥ 1.5x AVXL's 3.99%. David Dodd sees stronger capital base growth than competitor.
63.35%
≥ 1.5x AVXL's 2.15%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
1244.16%
Higher Total Debt Growth compared to AVXL's zero value, indicating worse performance.
-58.28%
Above 1.5x AVXL's -1.45%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.